Theron B T, Padmanabhan H, Aladin H, Smith P, Campbell E, Nightingale P, Cooper B T, Trudgill N J
Department of Gastroenterology, Sandwell General Hospital, West Bromwich, UK.
Welcome Trust Clinical Research Facility, University Hospitals Birmingham Foundation Trust, Birmingham, UK.
United European Gastroenterol J. 2016 Dec;4(6):754-761. doi: 10.1177/2050640616632419. Epub 2016 Feb 19.
Varying rates of oesophageal adenocarcinoma (OAC) complicating Barrett's oesophagus (BO) have been reported. Recent studies and meta-analyses suggest a lower incidence, questioning the value of endoscopic surveillance.
We aimed to retrospectively examine the rate of OAC, risk factors and causes of death in a prospectively recruited BO cohort.
Data from patients with BO from a cohort from 1982-2007 were studied. Patients were subdivided into surveyed, failed to attend surveillance and unfit for surveillance. Standardised mortality ratios (SMR) were calculated for common causes of death. Cox proportional hazards models were used to determine which factors were associated with progression to OAC.
In total, 671 BO patients (61% male) were studied; 37 (76% male) were diagnosed with OAC. OAC incidence was 0.47% per annum and stable across three decades (1982-1991 0.56%, 1992-2001 0.46%, 2002-2012 0.41% ( = 0.8)). All-cause mortality was increased for the whole cohort (SMR 163(95% CI 145-183)). Mortality from OAC appeared higher in patients who failed to attend surveillance (SMR 3216(95% CI 1543-5916)) compared with surveyed (SMR 1753(95% CI 933-2998)) and those unfit for surveillance due to co-morbidity (SMR 440(95% CI 143-1025)). Multivariable analysis identified low-grade dysplasia (HR 4.4(95% CI 1.56-12.43), = 0.005) and length of BO (HR 1.2(95% (1.1-1.3)), < 0.001)) as associated with OAC.
Progression to OAC appeared stable over three decades at 0.47% per annum. Patients with BO had a modest increase in all-cause mortality and a large increase in OAC mortality, particularly if fit for surveillance. Low-grade dysplasia and the length of the BO segment were associated with developing OAC.
已有报道称 Barrett 食管(BO)并发食管腺癌(OAC)的发生率各不相同。近期的研究和荟萃分析表明其发病率较低,这对内镜监测的价值提出了质疑。
我们旨在回顾性研究一个前瞻性招募的 BO 队列中 OAC 的发生率、危险因素及死亡原因。
对 1982 年至 2007 年一个队列中 BO 患者的数据进行研究。患者被分为接受监测组、未参加监测组和不适合监测组。计算常见死因的标准化死亡比(SMR)。使用 Cox 比例风险模型来确定哪些因素与进展为 OAC 相关。
总共研究了 671 例 BO 患者(61%为男性);37 例(76%为男性)被诊断为 OAC。OAC 的年发病率为 0.47%,在三十年中保持稳定(1982 - 1991 年为 0.56%,1992 - 2001 年为 0.46%,2002 - 2012 年为 0.41%(P = 0.8))。整个队列的全因死亡率有所增加(SMR 为 163(95%CI 145 - 183))。与接受监测的患者(SMR 为 1753(95%CI 933 - 2998))和因合并症不适合监测的患者(SMR 为 440(95%CI 143 - 1025))相比,未参加监测的患者 OAC 死亡率似乎更高(SMR 为 3216(95%CI 1543 - 5916))。多变量分析确定低级别异型增生(HR 为 4.4(95%CI 1.56 - 12.43),P = 0.005)和 BO 的长度(HR 为 1.2(95%(1.1 - 1.3)),P < 0.001)与 OAC 相关。
在三十年中进展为 OAC 的年发生率稳定在 0.47%。BO 患者的全因死亡率略有增加,OAC 死亡率大幅增加,特别是那些适合监测的患者。低级别异型增生和 BO 段的长度与发生 OAC 相关。